Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

167.49 -0.08 (-0.05%)
Streaming Delayed Price Updated: 10:18 AM EDT, Aug 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,679,613
Open 166.41
Bid (Size) 167.49 (1)
Ask (Size) 167.52 (1)
Prev. Close 167.57
Today's Range 166.41 - 167.54
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
NexImmune Pauses Developing Multiple Myeloma Hopeful, Citing Competition
NexImmune Inc (NASDAQ: NEXI) cited the competitive environment in the blood cancer space as the reason for  
Via Benzinga
BZ Chart Of The Day: Johnson & Johnson Is Nearing This Key Support Level
Johnson & Johnson (NYSE: JNJ) stock is oversold and getting close to a level that has been support in the past. Oversold refers to momentum. It means the stock has been aggressively sold so hard that... 
Via Benzinga

Performance

YTD
-2.36%
-2.36%
1 Month
-3.87%
-3.87%
3 Month
-6.34%
-6.34%
6 Month
+0.11%
+0.11%
1 Year
-5.82%
-5.82%

More News

Read More
Landmark Drug Pricing Reform Bill Passes Congress House
Via Benzinga
S&P 500, Nasdaq Log Longest Weekly Win Streaks of 2022
Via Talk Markets
Blue Water Vaccines: Early Stage Developer Of Infectious Disease Vaccines
Via Talk Markets
Johnson & Johnson To Stop Selling Talc-Based Powder
Via Benzinga
Blue Chip Stocks In Focus: Johnson & Johnson
Via Talk Markets
Benzinga Before The Bell: Johnson & Johnson To Stop Selling Talc-Based Powder, Google Fined $43M In Australia For Misleading Users Over Data Tracking, S&P Global Drops Coinbase Debt Rating And Other Top Financial Stories Friday, August 12
Via Benzinga
Stocks Take Pause Despite Surprise Drop In Inflation Data
Via Talk Markets
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
Via Benzinga
Agilis Consulting Group Appoints Former Johnson & Johnson Employee, Denise Wagner, as Principal Human Factors Consultant
Via Newswire.com
Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help
Via Investor's Business Daily
The 3 Best Sectors for a Bear Market
Via InvestorPlace
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
Via Investor Brand Network
Exposures Product Safety
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
Via FinancialNewsMedia
Exposures Product Safety
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Via MarketBeat
Topics ETFs
Exposures COVID-19
Why Is Novavax (NVAX) Stock Plunging 30%?
Via InvestorPlace
3 Dividend Stocks to Buy to Beat Runaway Inflation
Via InvestorPlace
The 3 Best Vanguard Funds to Buy in August
Via InvestorPlace
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
From Johnson & Johnson
Via Business Wire
3 Blue-Chip Stocks With Rock-Solid Dividends
Via Talk Markets
Is Church & Dwight Co. Inc. (NYSE: CHD) a Buy for Dividend Investors?
Via MarketBeat
Johnson & Johnson Whale Trades Spotted
Via Benzinga
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.